Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.jacbts.2020.10.003 http://scihub22266oqcxt.onion/10.1016/j.jacbts.2020.10.003 33102950!7566794!33102950     free     free     free Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 233.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JACC+Basic+Transl+Sci 2021 ; 6 (1): 1-8 Nephropedia Template TP {{tp|p=33102950|t=2021. The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection |pdf=|usr=}}{{33102950}} gab.com Text The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection JO: JACC Basic Transl Sci http://www.kidney.de/pget.php?&tw=1&pmid=33102950 #FOAvip Many efforts to design and screen therapeutics for the current severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic have focused on inhibiting viral host cell entry by disrupting angiotensin-converting enzyme-2 (ACE2) binding with the SARS-CoV-2 spike protein. This work focuses on the potential to inhibit SARS-CoV-2 entry through a hypothesized alpha5beta1 integrin-based mechanism and indicates that inhibiting the spike protein interaction with alpha5beta1 integrin (+/- ACE2) and the interaction between alpha5beta1 integrin and ACE2 using a novel molecule (ATN-161) represents a promising approach to treat coronavirus disease-19. Twit Text FOAVip The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection ????JACC Basic Transl Sci http://www.kidney.de/pget.php?&tw=1&pmid=33102950 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33102950 #FOAvip English Wikipedia <ref>{{Cite pmid|33102950}}</ref> The Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV-2 Infection #MMPMID33102950 Beddingfield BJ; Iwanaga N; Chapagain PP; Zheng W; Roy CJ; Hu TY; Kolls JK; Bix GJ JACC Basic Transl Sci 2021[Jan]; 6 (1): 1-8 PMID33102950show ga Many efforts to design and screen therapeutics for the current severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) pandemic have focused on inhibiting viral host cell entry by disrupting angiotensin-converting enzyme-2 (ACE2) binding with the SARS-CoV-2 spike protein. This work focuses on the potential to inhibit SARS-CoV-2 entry through a hypothesized alpha5beta1 integrin-based mechanism and indicates that inhibiting the spike protein interaction with alpha5beta1 integrin (+/- ACE2) and the interaction between alpha5beta1 integrin and ACE2 using a novel molecule (ATN-161) represents a promising approach to treat coronavirus disease-19. äThe Integrin Binding Peptide, ATN-161, as a Novel Therapy for SARS-CoV(epmc).pdf DeepDyve Pubget Overpricing